Cough Reduction in IPF With Nalbuphine ER

PHASE2CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

February 6, 2024

Primary Completion Date

April 24, 2025

Study Completion Date

April 24, 2025

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

NAL ER

Oral tablets

DRUG

Placebo

Oral tablets

DRUG

NAL ER

Oral Tablets

DRUG

NAL ER

Oral tablets

Trial Locations (59)

2139

Concord Repatriation General Hospital, Concord

2145

Westmead Hospital, Westmead

3084

Austin Hospital, Heidelberg

3128

Eastern Health-Box Hill Hospital, Box Hill

5067

Respiratory Clinical Trials Pty Ltd, Kent Town

6163

TrialsWest Pty Ltd, Spearwood

7070

Akdeniz University Faculty of Medicine, Antalya

17020

Canakkale Onsekiz Mart Universitesi (COMU) - Tip Fakultesi Hastanesi, Çanakkale

20900

Azienda Ospedaliera San Gerardo di Monza, Monza

28010

Hospital La Milagrosa, Madrid

30625

Medizinische Hochschule Hannover, Hannover Medical School, Hanover

34854

Sureyyapasa Gogus Hastaliklari ve Gogus Cerrahisi Egitim ve Arastirma Hastanesi, Istanbul

35100

Ege University Medical Faculty, Izmir

35128

Azienda Ospedaliera di Padova, Padua

39008

HUMV, Santander

42130

Selcuk Universty Medical Faculty, Konya

42699

Krankenhaus Bethanien, Solingen

45239

Universitatsklinik Ruhrlandklinik, Westdeutsches Lungenzentrum, Essen

55128

IKF Pneumologie Mainz, Helix Medical Excellence Center Mainz, Mainz

55131

University Medical Center of Johannes Gutenberg-University Mainz, Mainz

60596

IKF Institut fuer klinische Forschung Frankfurt, Frankfurt am Main

71122

Azienda Ospedaliero Universitaria Ospedali Riuniti Di Foggia, Foggia

95123

Azienda Ospedaliero - Universitaria Policlinico - Vittorio Emanuele- Ospedale Gaspare Rodolico, Catania

2260877

Centro de Investigaciones Medicas Cemedin Ltda., Quillota

2352499

Hospital Carlos Van Buren, Valparaíso

2520598

Oncocentro APYS, Viña del Mar

3467384

Centro de Investigacion del Maule, Talca

4040324

Hospital Clinico Regional Dr. Guillermo Grant Benavente, Concepción

7620157

Clinica Universidad de los Andes, Santiago

G8T 7A1

CIC Mauricie Inc., Trois-Rivières

L1S 2J5

Dynamic Drug Advancement, Ajax

V5Z 1M9

Centre for Lung Health Clinic, Vancouver

V6Z 1Y6

The Pacific Lung Health Centre - St. Pauls Hospital, Vancouver

04103

University Hospital of Leipzig, Leipzig

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

5223 GZ

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

9728 NT

Martini Ziekenhuis, Groningen

3015 GD

Erasmus Medisch Centrum 1, Rotterdam

2512 VA

HMC (Haaglanden Medisch Centrum) Bronovo, The Hague

80-214

Uniwersyteckie Centrum Kliniczne (UCK), Gdansk

90-153

Uniwersytecki Szpital Kliniczny nr 1 im. N. Barlickiego, Lodz

10-357

Warminsko Mazurskie Centrum Chorob Pluc w Olsztynie, Olsztyn

70-891

Samodzielny Publiczny Wojewodzki Szpital Zespolony w Szczecinie, Szczecin

08017

Clinica Mi Tres Torres Barcelona, Barcelona

08907

Hospital Universitari de Bellvitge, Barcelona

06010

Gulhane Askeri Tip Akademisi (GATA) - Gulhane Askeri Tip Fakultesi (Gulhane Military Medical Academy and Medical School), Ankara

B15 2GW

Queen Elizabeth Hospital Birmingham - University Hospitals Birmingham NHS Foundation Trust, Birmingham

CB2 0AY

Royal Papworth Hospital, Cambridge

HU16 5JQ

Hull and East Yorkshire - Castle Hill Hospital, Cottingham

EH16 4SA

Royal Infirmary Of Edinburgh, Edinburgh

NW1 2PG

University College London, London

SW3 6NP

Royal Brompton Hospital, London

BT47 6SB

Altnagelvin Area Hospital, Londonderry

M23 9LT

Wythenshawe Hospital, Manchester

NR4 7UY

Norfolk and Norwich University Hospital, Norwich

NG5 1PB

Nottingham City Hospital, Nottingham

OX3 7LE

Churchill Hospital, Oxford

BT63 5QQ

Southern Health & Social Care Trust, Craigavon Area Hospital, Portadown

SO16 6YD

Southampton General Hospital, Southampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Trevi Therapeutics

INDUSTRY

NCT05964335 - Cough Reduction in IPF With Nalbuphine ER | Biotech Hunter | Biotech Hunter